Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres

Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres Key Takeaways Stanford's ageotypes framework revolutionizes aging assessment by identifying four distinct aging patterns—metabolic, immune, hepatic, and nephrotic—enabling personalized longevity interventions beyond traditional approaches. • Telomeres alone are insufficient: Individual variation and tissue-specific differences

Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres